How much funding has Brickbio raised?

Brickbio has disclosed $5M raised across 1 round.

Where is Brickbio headquartered?

Brickbio is headquartered in Boston, US.

Brickbio

Boston, US · Founded 2019 · Delaware corporation

BrickBio develops protein and antibody-drug conjugate (ADC) therapeutics using its Evolved tRNA Localization (ETRNAL) platform, which incorporates synthetic amino acid conjugation handles at specific sites in a protein backbone via mammalian expression systems. The company targets pharmaceutical and biotech applications, aiming to produce more stable and efficacious conjugated biologics, including multi-payload conjugates.

Biotech Deep Tech

Founders & leadership

Scott ShermanNamed on SEC filing

Alexander RobertsonNamed on SEC filing

Elouise ManhertzNamed on SEC filing

Caylin NavoNamed on SEC filing

John BoyceinNamed on SEC filing

Cheri WalkerNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$5M disclosed across 1 round · 2019

▶$5MraisedNov 2019 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Scott ShermanExecutive Officer, Director
Alexander RobertsonExecutive Officer
Elouise ManhertzExecutive Officer
Caylin NavoExecutive Officer
John BoyceDirector
Cheri WalkerDirector

Offering amount: $5M
Amount sold: $5M
First sale: Nov 2019
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap

Bridgebio11 shared keywordsBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.

ClickBio, Inc.7 shared keywordsClickBio designs and manufactures laboratory automation tools and consumables, such as its Smarter Reagent Fill Station, an automation-ready on-deck reservoir with USB-B connectivity and serial command control for continuous media replenishment. The products target life science labs for applications including Next Generation Sequencing (NGS) and cell culture, built by a team of mechanical engineers and scientists.

AskBio6 shared keywordsAskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.

Generate Biomedicines4 shared keywordsGenerate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering. The company creates new drugs on demand across diverse biologic modalities for immunology, oncology, infectious disease, and vaccines.

Eclipse Bio4 shared keywordsEclipsebio provides RNA biology analytical services and sequencing-based assays that help drug developers and researchers characterize RNA at nucleotide-level resolution and generate datasets for AI-driven drug discovery. It serves pharma, biotech, and academic partners working on oligonucleotides, RNA-targeting small molecules, and fundamental RNA research.

Companies competing with Brickbio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Brickbio do?: BrickBio develops protein and antibody-drug conjugate (ADC) therapeutics using its Evolved tRNA Localization (ETRNAL) platform, which incorporates synthetic amino acid conjugation handles at specific sites in a protein backbone via mammalian expression systems. The company targets pharmaceutical and biotech applications, aiming to produce more stable and efficacious conjugated biologics, including multi-payload conjugates.
How much funding has Brickbio raised?: Brickbio has disclosed $5M raised across 1 round.
Where is Brickbio headquartered?: Brickbio is headquartered in Boston, US.